Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery
NCT00770705Phase 2Withdrawn
- Sponsor
- Vanderbilt University
- Start
- Oct 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phenoxybenzamine in hypoplastic left heart syndrome (HLHS), sponsored by Vanderbilt University. Planned start Oct 2008; status: withdrawn.
02
Drugs
phenoxybenzamine
03
Conditions
hypoplastic left heart syndrome (HLHS)
Beyond the preview
Go deeper on NCT00770705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770705.